ICU-SUCCEED for Acute Respiratory Failure

(ICU-SUCCEED Trial)

BW
Overseen ByBlair Wendlandt, MD, MSCR
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of North Carolina, Chapel Hill

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will investigate whether a family-centered intervention that has been adapted for patients with critical illness and their caregivers is possible, acceptable, and helpful

Who Is on the Research Team?

BW

Blair Wendlandt, MD, MSCR

Principal Investigator

University of North Carolina, Chapel Hill

Are You a Good Fit for This Trial?

This trial is for people who survived a serious illness that caused breathing failure and were treated in the ICU, as well as their caregivers. Participants must be recovering from conditions like sepsis, severe low oxygen, or toxic shock syndrome.

Inclusion Criteria

My caregiver is at least 18 years old.
Caregiver is related to the patient as a spouse or domestic partner, adult child, parent, or sibling
I am in the UNC ICU with severe breathing problems or sepsis affecting my organs.
See 8 more

Exclusion Criteria

Caregiver does not provide emotional, physical, and/or financial support to the patient in a non-professional, unpaid capacity
Patient has no available family caregiver
Patient unhoused prior to admission
See 12 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive the ICU-SUCCEED intervention, including one inpatient session and four outpatient sessions via Zoom or telephone

8 weeks
1 inpatient visit, 4 outpatient sessions (Zoom or telephone)

Follow-up

Participants are monitored for safety and effectiveness, with assessments at Day 90

90 days
Day 90 assessment

What Are the Treatments Tested in This Trial?

Interventions

  • ICU-SUCCEED

Trial Overview

The study compares a new family-centered support program called ICU-SUCCEED to standard care. It aims to see if this program helps patients and caregivers after critical illness and if it can be used easily.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: ICU-SUCCEEDExperimental Treatment1 Intervention
Group II: Augmented Usual CarePlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of North Carolina, Chapel Hill

Lead Sponsor

Trials
1,588
Recruited
4,364,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+